Mannitol Vioser

Mannitol, the active ingredient in Mannitol Vioser, is an osmotic diuretic presented as a solution for injection for intravenous use. It reduces intracranial and intraocular pressure and promotes diuresis in acute kidney injury. GNH USA supplies Mannitol Vioser as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Mannitol is an osmotic diuretic used in conditions where fluid shifts reduce pressure or support renal function. - Reduction of intracranial pressure: lowers cerebral edema and intracranial pressure. - Reduction of intraocular pressure: decreases ocular fluid volume to relieve pressure. - Renal protection in acute kidney injury: enhances renal perfusion and promotes urine output. - Promotion of diuresis: increases urinary volume in fluid‑overload states.

Mannitol may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate discomfort. - Nausea: feeling of queasiness often with occasional vomiting. - Thirst: increased desire for fluids. - Electrolyte imbalance (e.g., hyponatremia): mild disturbances in serum electrolytes.

Serious or Rare Side Effects: - Acute renal failure: sudden loss of kidney function. - Pulmonary edema: fluid accumulation in the lungs. - Anaphylactic reaction: severe allergic response requiring immediate medical attention.

Mannitol Vioser requires careful clinical monitoring. - Monitor renal function: assess serum creatinine and urine output. - Check serum electrolytes: watch for sodium and potassium shifts. - Avoid rapid infusion in heart‑failure patients: may worsen fluid overload. - Use caution in dehydrated individuals: risk of further volume depletion. - Adjust dosing in elderly patients: increased sensitivity to osmotic effects. - Store at ambient temperature: keep in original container, protect from moisture and direct light.

Mannitol can interact with several drug classes.

Major Interactions (Avoid): - Loop diuretics: may cause excessive diuresis and electrolyte loss. - Lithium: increased risk of lithium toxicity. - ACE inhibitors: additive renal effects and hypotension. - Antihypertensives: may produce synergistic blood‑pressure lowering.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce the diuretic response. - Carbamazepine: may increase Mannitol clearance, altering efficacy. - Aminoglycosides: heightened risk of nephrotoxicity when combined.